Security Snapshot

InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR) Institutional Ownership

CUSIP: 45779A846

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

36

Shares (Excl. Options)

21.53MFull value: 21,529,072 · shares · 30 Jun 2026

Price

$0.70

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
NSPR on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
21,529,072
Latest holder snapshot 5 signals
Total 13F value
$15,071,168
Portfolio coverage rank
0%
Share change
-1,273,438
Value change
-$1,132,885
Number of holders
36
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
48,244,715
SEC-reported price per share
$0.50
Insider filing price
$0.50
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 45779A846.
  • 36 institutions reported positions in Q2 2026.
  • 11 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 34 to 36 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $37.17MFull value: $37,167,726 · USD · 31 Mar 2026
    to
    $15.07MFull value: $15,071,168 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 36 institutions filings for Q2 2026.

Open SEC evidence

Security key

45779A846

13F reference period

Q2 2026

13F holders

36

13D/G owners

11

CIK / CUSIP context first

Open Q2 2026 holders NSPR full holder history InspireMD, Inc. SEC filings InspireMD, Inc. company facts InspireMD, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
11
Security
NSPR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MARSHALL WACE, LLP 10% $67,729,915 28,103,699 MARSHALL WACE, LLP 30 Sep 2025
Rosalind Advisors, Inc. 9.2% -2.2% $19,557,045 10,987,104 0% Rosalind Advisors, Inc. 31 Dec 2025
Nantahala Capital Management, LLC 10% 0% $6,458,327 +$755,650 4,819,647 +13% Nantahala Capital Management, LLC 31 Mar 2026
Lawless Michael A 8.6% $8,711,502 3,614,731 Michael A. Lawless 26 Jun 2025
Aberdeen Group plc 7.5% +26% $5,648,588 +$1,232,200 3,173,364 +28% Aberdeen Group plc 31 Dec 2025
ORBIMED ADVISORS LLC 7.4% +82% $5,577,461 +$1,780,000 3,133,405 +47% ORBIMED ADVISORS LLC 31 Dec 2025
Slosman Marvin 5.2% $4,167,519 2,556,760 Marvin Slosman 22 Jan 2026
Parkman Healthcare Partners LLC 5.8% $5,881,926 2,440,633 Parkman Healthcare Partners LLC 30 Sep 2025
Nantahala Capital Partners Limited Partnership 5.7% $5,827,419 2,418,016 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
Velan Capital Investment Management LP 5% -2.2% $3,146,024 +$273,469 2,347,779 +9.5% Velan Capital Master Fund LP 31 Mar 2026
Shore Craig 3.5% $3,577,657 1,484,505 Craig Shore 26 Jun 2025
As of 30 Jun 2026, 36 institutional investors reported holding
21.53MFull value: 21,529,072 · shares · 30 Jun 2026
shares of InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR). This represents 45% of the company’s total
48.24MFull value: 48,244,715 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
44%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Rosalind Advisors, Inc. 8.1% 3,905,743 0% 1% $2,734,411
Aberdeen Group plc 7.7% 3,698,364 +17% 0% $2,589,225
Nantahala Capital Management, LLC 7% 3,376,484 0% 0.14% $2,363,876
ORBIMED ADVISORS LLC 6.5% 3,133,405 0% 0.04% $2,193,697
Parkman Healthcare Partners LLC 5% 2,416,518 0% 0.17% $1,691,804
MARSHALL WACE, LLP 3.9% 1,860,405 0% 0% $1,302,284
Soleus Capital Management, L.P. 2.2% 1,045,708 0% 0.03% $732,100
PURA VIDA INVESTMENTS, LLC 0.93% 450,517 0% 0.85% $315,407
INGALLS & SNYDER LLC 0.76% 368,800 -2.8% 0.01% $258,000
Affiance Financial, LLC 0.52% 250,370 0% 0.03% $175,284
Velan Capital Investment Management LP 0.31% 148,138 -93% 0.06% $103,711
BlackRock, Inc. 0.25% 122,993 +53% 0% $86,108
RENAISSANCE TECHNOLOGIES LLC 0.23% 112,832 +541% 0% $78,994
Creative Planning 0.23% 108,964 +453% 0% $76,286
Schonfeld Strategic Advisors LLC 0.21% 99,275 0% $69,502
HRT FINANCIAL LP 0.12% 59,754 0% $41,000
XTX Topco Ltd 0.1% 49,029 +297% 0% $34,325
Centiva Capital, LP 0.09% 44,123 +78% 0% $30,891
MILLENNIUM MANAGEMENT LLC 0.08% 37,677 -66% 0% $26,378
COURIER CAPITAL LLC 0.06% 30,000 0% 0% $21,003
Mesirow Financial Investment Management, Inc. 0.06% 30,000 0% 0% $21,003
MORGAN STANLEY 0.06% 28,371 -29% 0% $19,863
VESTIA PERSONAL WEALTH ADVISORS 0.05% 24,425 0% 0.01% $17,100
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.04% 20,594 0% $14,418
Cambridge Investment Research Advisors, Inc. 0.04% 20,166 0% $14,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
22
Headline period
Q2 2026
Rows shown
1-22 of 22
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 4,186,744 $2,808,852 -$6,149 $0.67 10
2026 Q2 21,529,072 $15,071,168 -$1,132,885 $0.70 36
2026 Q1 22,802,483 $37,167,726 -$616,988 $1.63 34
2025 Q4 23,169,255 $41,235,253 -$50,631 $1.78 44
2025 Q3 22,730,210 $54,778,990 +$20,913,736 $2.41 40
2025 Q2 14,061,920 $31,922,818 +$2,512,314 $2.27 36
2025 Q1 12,917,013 $34,746,467 +$554,615 $2.69 34
2024 Q4 12,710,904 $33,407,511 +$811,860 $2.63 29
2024 Q3 12,402,374 $33,215,449 +$1,209,473 $2.68 27
2024 Q2 11,951,922 $29,859,952 +$4,430,429 $2.50 23
2024 Q1 10,178,288 $23,962,111 -$399,400 $2.37 25
2023 Q4 10,339,444 $29,052,785 +$1,719,804 $2.81 27
2023 Q3 8,762,240 $28,676,783 +$2,327,230 $3.27 25
2023 Q2 8,054,251 $20,221,241 +$20,007,582 $2.51 22
2023 Q1 88,752 $103,127 -$54,760 $1.12 12
2022 Q4 155,809 $137,173 +$21,576 $0.86 14
2022 Q3 112,334 $168,630 -$78,516 $1.50 11
2022 Q2 129,060 $256,202 -$10,358 $1.99 10
2022 Q1 140,275 $455,524 -$96,895 $3.21 13
2021 Q4 172,505 $527,325 -$27,335 $3.02 15
2021 Q3 170,103 $703,514 -$1,360,154 $4.10 12
2021 Q2 450,832 $2,277,560 +$2,277,560 $5.05 14
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .